Prostate Cancer Expert On New Study

Researchers at Washington University School of Medicine in St. Louis have found that prostate  cancer screening with prostate specific antigen showed no obvious prostate cancer mortality benefit in a study of 76,000 men over 10 to 13 years.  Prostate cancer expert Gerald L. Andriole, Chief, Division of Urologic Surgery and Director, Men's Health Center at Barnes-Jewish Hospital in St. Louis says “The message is that routine mass screening is not the way to go.”

Read more: http://urology.wustl.edu/Physicians.